Avadel Pharmaceuticals (NasdaqGM:AVDL) FY Conference September 10, 2025 09:30 AM ET Company ParticipantsThomas McHugh - CFOSusan Rodriguez - COOGregory J. Divis - CEOConference Call ParticipantsMarc Goodman - AnalystSusan RodriguezYou know, looking at the response that physicians had to the very innovative profile of LUMRYZ, an extended release delivery technology that enables once at bedtime full therapeutic dose delivery with the dose delivered aligned with the patient's natural sleep cycle and the opport ...